A 2023 Agenda for Substance Use Prevention and Treatment in the US

Rahul Gupta; Nicholas F Wright; David R Holtgrave

doi:10.1001/jama.2023.1090

A 2023 Agenda for Substance Use Prevention and Treatment in the US

JAMA. 2023 Mar 7;329(9):707-708. doi: 10.1001/jama.2023.1090.

Authors

Rahul Gupta¹, Nicholas F Wright¹, David R Holtgrave¹

Affiliation

¹ White House Office of National Drug Control Policy, Washington, DC.

PMID: 36745417
DOI: 10.1001/jama.2023.1090

No abstract available

Plain language summary

In this Viewpoint, officials from the White House Office of National Drug Control Policy describe 3 actions that health care personnel can take to expand prevention and treatment of substance misuse and overdose.

MeSH terms

Analgesics, Opioid / therapeutic use
Drug Overdose / etiology
Drug Overdose / prevention & control
Health Policy*
Humans
Opioid-Related Disorders / drug therapy
Opioid-Related Disorders / prevention & control
Opioid-Related Disorders / therapy
Substance-Related Disorders* / complications
Substance-Related Disorders* / drug therapy
Substance-Related Disorders* / prevention & control
Substance-Related Disorders* / therapy
United States

Substances

Analgesics, Opioid